Duchenne Muscular Dystrophy Research Solutions

Date Published:

Watch our video to learn how our digital solutions and clinical science expertise can advance the development of new therapeutic options for Duchenne muscular dystrophy by helping to:

  • Ensure high-quality data captured from movement assessments
  • Reduce expectation bias & excessive placebo response by training raters to administer/score assessments consistently
  • Enable remote clinical supply management to reduce participation burdens and site visits
  • Provide guidance for building your protocol and optimizing trial conduct